Influenza A virus activates the unfolded protein response and induces the accumulation of insoluble protein aggregates that are essential for efficient viral propagation
M. Marques, B. Ramos, H. Albuquerque, M. Pereira, D. R. Ribeiro, A. Nunes, J. Sarabando, D. Bras, A. R. Ferreira, R. Vitorino, M. J. Amorim, A. Silva, A. R. Soares, D. Ribeiro
Abstract
Influenza A virus (IAV) is one of the main causes of annual respiratory epidemics in humans. IAV employs multiple strategies to evade host immunity and hijack cellular mechanisms to support proper virion formation and propagation. Some of these strategies encompass the manipulation of pathways involved in protein homeostasis, leading to changes in the host proteome and protein distribution within the cell. In this study, we performed a detailed analysis of the interplay between IAV and the host cells proteostasis mechanisms throughout the entire infectious cycle. We reveal that IAV infection induces the activation of the inositol requiring enzyme 1 (IRE1) branch of the unfolded protein response (UPR), at an infection stage that coincides with high rates of viral protein translation. This activation is particularly important for infection, as attenuation of virus production was observed upon IRE1 inhibition. Concomitantly to UPR activation, we observed the accumulation of virus-induced insoluble protein aggregates, which contain both viral and host proteins and are associated with a dysregulation of the host cell RNA metabolism. We demonstrate that this accumulation is important for IAV propagation, as its prevention using a quinoline-steroid hybrid compound significantly reduces the number of produced infectious virus particles. Our data suggests that the formation of these insoluble protein aggregates favors the final steps of the infection cycle, more specifically the virion assembly. Our findings reveal additional mechanisms by which IAV disrupts the host cell proteostasis to favor infection and uncover new cellular targets that can be explored for the development of host-directed antiviral strategies.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Thiopurines activate an antiviral unfolded protein response that blocks viral glycoprotein accumulation in cell culture infection model
P. D. Slaine, M. Kleer, … D. A. Khaperskyy·bioRxiv·Sep 30, 2020
- Identification and characterization of interactions between Influenza A Virus NS1 protein and the human ubiquitin proteasome system
Laurie-Anne Lamotte, Samuel Kindylides, … Lionel Tafforeau·bioRxiv·Oct 5, 2023
- Influenza A virus-induced production of PI4P at the endoplasmic reticulum involves ATG16L1 and promotes the egress of viral ribonucleoproteins
Carla Alemany, Juliane Da Graça, … Nadia Naffakh·PLoS BiologyPeer-reviewed·Jul 16, 2025
- Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection
J. Del Sarto, V. Gerlt, … S. Ludwig·bioRxiv·Jan 22, 2021
- Stress granule-inducing eukaryotic translation initiation factor 4A inhibitors block influenza A virus replication
P. D. Slaine, M. Kleer, … C. McCormick·bioRxiv·Oct 2, 2017
- Influenza A M2 recruits M1 to the plasma membrane: a fluorescence fluctuation microscopy study
A. Petrich, V. Dunsing, … S. Chiantia·bioRxiv·May 6, 2021